Rhenman & Partners Asset Management Ab Royalty Pharma PLC Transaction History

Rhenman & Partners Asset Management Ab

$766 Million
Q2 2025

A detailed history of Rhenman & Partners Asset Management Ab transactions in Royalty Pharma PLC stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 344,000 shares of RPRX stock, worth $12.5 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares

344,000

Previous 411,000 16.3%

Holding current value

$12.5 Million

Previous $12.8 Million 3.13%

% of portfolio

1.62%

Previous 1.52%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$30.85 - $36.14 $2.07 Million - $2.42 Million	-67,000 Reduced 16.3%	344,000 $12.4 Million
Q1 2025 May 14, 2025	SELL	$25.75 - $33.86 $4.74 Million - $6.23 Million	-184,000 Reduced 30.92%	411,000 $12.8 Million
Q4 2024 Feb 13, 2025	SELL	$24.28 - $28.39 $449,180 - $525,215	-18,500 Reduced 3.02%	595,000 $15.2 Million
Q3 2024 Nov 13, 2024	BUY	$25.63 - $29.27 $1.76 Million - $2.01 Million	68,803 Added 12.63%	613,500 $17.4 Million
Q1 2024 May 14, 2024	BUY	$27.46 - $31.33 $3.16 Million - $3.6 Million	115,000 Added 26.76%	544,697 $16.5 Million
Q4 2023 Feb 13, 2024	BUY	$26.21 - $29.22 $7.33 Million - $8.17 Million	279,697 Added 186.46%	429,697 $12.1 Million
Q3 2023 Nov 13, 2023	SELL	$26.26 - $31.38 $2.73 Million - $3.26 Million	-103,832 Reduced 40.91%	150,000 $4.07 Million
Q3 2023 Nov 09, 2023	BUY	$26.26 - $31.38 $2.73 Million - $3.26 Million	103,832 Added 69.22%	253,832 $6.89 Million
Q2 2023 Aug 11, 2023	SELL	$29.6 - $36.56 $444,000 - $548,400	-15,000 Reduced 9.09%	150,000 $4.61 Million
Q1 2023 May 11, 2023	SELL	$32.77 - $39.4 $1.64 Million - $1.97 Million	-50,000 Reduced 23.26%	165,000 $5.94 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $2.59 Million - $2.9 Million	65,000 Added 43.33%	215,000 $9.1 Million
Q2 2022 Aug 12, 2022	BUY	$37.53 - $44.22 $5.63 Million - $6.63 Million	150,000 New	150,000 $6.31 Million
Q2 2021 Aug 13, 2021	SELL	$39.85 - $46.63 $5.18 Million - $6.06 Million	-130,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$42.34 - $52.82 $5.08 Million - $6.34 Million	-120,000 Reduced 48.0%	130,000 $5.67 Million
Q4 2020 Jan 19, 2021	BUY	$36.12 - $50.05 $9.03 Million - $12.5 Million	250,000 New	250,000 $12.5 Million

Others Institutions Holding RPRX

# of Institutions

497

Shares Held

307M

Call Options Held

1.99M

Put Options Held

384K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.9B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account

Rhenman & Partners Asset Management Ab Royalty Pharma PLC Transaction History